OUR EXPERTISE IS WHAT MAKES US DIFFERENT
Drug Development in general and especially Clinical Development consists of a network of complex and interconnected pathways and processes, regulated by an extensive list of rules and directives set forth by the legislators. Accelsiors will help you find the shortest and the most efficient way through this labyrinth. By eliminating road-blocks on the path of your clinical trial, we clear the way to proceed in a time and cost efficient manner. We want to assist and support our clients from pharmaceutical, biotechnology and medical device industries in achieving their goals in all phases of clinical product development.
Our approach to any clinical work is guided by the following basic strategy:
- Understanding the science
- Evaluating study design
- Reducing cost through process optimization and timeline harmonization
- Increasing added value by building in early indications, resource efficient solutions
To achieve these strategies, Accelsiors:
- Provides high quality, integrated and customized expertise;
- Highly standardizes its management process through its proprietary PACE program 
- Prepares innovative product development plans and implements highly effective regulatory strategies
- Closely monitors the program progress
- Provides experienced and talented staff
Accelsiors has been working in many indications, however our experience and expertise is significant in the following fields:
- Biosimilars (from simple peptides to complex monoclonals)
- Respiratory disorders;
- Infectious diseases;
- Autoimmune disorders;
- Orphan disorders;
- Pediatric studies.
Our experience spans from small molecules to complex therapeutic proteins like monoclonal antibodies, or vaccines. Over the course of the last 18 years, Accelsiors became a recognized and respected expert CRO in the multitude of indications such as endocrinology with focus on Hypothalamo pituitary disorders, Neurology, Hepatology and other indications. In addition to its biosimilar and Biobetter expertize, Accelsiors gained considerable experience in the development of innovative biologics, targeting the epigenetics or molecular immunology mechanisms.
We firmly believe that proper scientific and medical understanding of investigational products, and studied indications are the key for the successful clinical trial conduct.
We attract our Sponsors and investigators with a scientific approach and knowledge. Hence, our strength lays in successfully conducting complex, difficult to recruit clinical trials. We have led a number of projects all the way from Proof of Concept through Phase III trials, and are happy to say that a substantial portion of our revenue is coming from repeat business.
Our Therapeutic and Indication focus has evolved based on our scientific and medical people skills that we have attracted to Accelsiors over the past 18 years.
Accelsiors designed, managed and monitored multiple Phase I, Phase II, and Phase III clinical trials with involvement of complex clinical, PK/PD, population PK, patients’ reported outcome, immunological, or imaging assessments endpoints.
In addition to standard patient population, Accelsiors is an expert in pediatric clinical trials and orphan disorders.
We have strategically located our offices and staff to ensure that we have ready access to our network of proven Investigators and subject matter experts in the studied indication. Additionally, this has provided us with a clear understanding of the regulatory and ethics requirements unique to each country.
Accelsiors delivers studies on time and with high quality. To achieve this, one of the key points is to understand project/indication/population specifics in the tiniest detail and to tailor the geographic spread of a study based on this. With us, you can reach key regions and our ability to deliver a study on time and with high quality is the key for success of our clients’ projects.
 PACE stands for "Plan, Accelerate, Control and Execute" which is our specific study management methodology program.